Jacobs, M., Geiger, M., Summers, S., Janes, T., Boyea, R., Zinn, K., . . . Spence, D. (2022). Interferon‑β Decreases the Hypermetabolic State of Red Blood Cells from Patients with Multiple Sclerosis. ACS Chemical Neuroscience, 13(17), 2658-2665. https://doi.org/10.1021/acschemneuro.2c00332
Chicago Style (17th ed.) CitationJacobs, M., M. Geiger, S. Summers, T. Janes, R. Boyea, K. Zinn, R. Aburashed, and D. Spence. "Interferon‑β Decreases the Hypermetabolic State of Red Blood Cells from Patients with Multiple Sclerosis." ACS Chemical Neuroscience 13, no. 17 (2022): 2658-2665. https://doi.org/10.1021/acschemneuro.2c00332.
MLA (9th ed.) CitationJacobs, M., et al. "Interferon‑β Decreases the Hypermetabolic State of Red Blood Cells from Patients with Multiple Sclerosis." ACS Chemical Neuroscience, vol. 13, no. 17, 2022, pp. 2658-2665, https://doi.org/10.1021/acschemneuro.2c00332.